Sacroiliac Joint Fusion Market Size & Share, By Indication (Degenerative Sacroiliitis, Sacral Disruption), Treatment Type (Surgery, Injections), End-user, Regional Forecast, Industry Players, Growth Statistics Report 2024-2032

Market Outlook:

Sacroiliac Joint Fusion Market surpassed USD 735.62 Million in 2023 and is poised to exceed USD 2.74 Billion by end of the year 2032, growing at over 20.2% CAGR between 2024 and 2032.

• Base Year Value (2023): USD 735.62 Million
• CAGR (2024-2032): 20.2%
• Forecast Year Value (2032): USD 2.74 Billion
• Historical Data Period: 2019-2023
• Largest Region: North America
• Forecast Period: 2024-2032

Market Dynamics:

Growth Drivers & Opportunity:

One major growth driver for the sacroiliac joint fusion market is the increasing prevalence of chronic lower back pain among the global population. According to the World Health Organization, lower back pain is the leading cause of disability worldwide, and sacroiliac joint dysfunction is a common underlying cause. As awareness of this condition grows and diagnostic techniques improve, the demand for sacroiliac joint fusion procedures is expected to increase significantly in the coming years.

Another key growth driver is the rising adoption of minimally invasive surgical techniques for sacroiliac joint fusion. Minimally invasive procedures offer several advantages over traditional open surgery, including shorter recovery times, reduced post-operative pain, and lower risk of complications. As more healthcare providers and patients become aware of the benefits of minimally invasive sacroiliac joint fusion, the market for these procedures is projected to expand rapidly.

Report Scope

Report Coverage	Details
Segments Covered	Indication, Treatment Type, End-User
Regions Covered	• North America (United States, Canada, Mexico) • Europe (Germany, United Kingdom, France, Italy, Spain, Rest of Europe) • Asia Pacific (China, Japan, South Korea, Singapore, India, Australia, Rest of APAC) • Latin America (Argentina, Brazil, Rest of South America) • Middle East & Africa (GCC, South Africa, Rest of MEA)
Company Profiled	SI-BONE, PainTEQ, CornerLoc, SIGNUS Medizintechnik, Globus Medical, Orthofix Medical, Life Spine, Camber Spine Technologies, LLC, CoreLink Surgical, Xtant Medical, Surgalign Spine Technologies, Medtronic

Industry Restraints:

However, despite the significant growth opportunities in the sacroiliac joint fusion market, there are also some key restraints that may hinder market growth. One major restraint is the high cost associated with sacroiliac joint fusion procedures. These surgeries can be expensive, especially for patients who do not have adequate insurance coverage. As a result, cost may be a significant barrier to access for some patients, limiting the overall market potential for sacroiliac joint fusion.

Another important restraint is the limited reimbursement coverage for sacroiliac joint fusion by insurance providers. While the efficacy of these procedures is well-documented, insurance coverage for sacroiliac joint fusion can vary significantly depending on the patient's insurance plan and provider. As a result, some patients may face challenges in obtaining coverage for these procedures, potentially leading to decreased demand and market growth for sacroiliac joint fusion in certain regions.

Regional Forecast:

North America:

The Sacroiliac Joint Fusion market in North America is expected to witness significant growth due to the rising prevalence of sacroiliac joint disorders, increasing adoption of minimally invasive surgical procedures, and growing geriatric population. In the United States, factors such as the availability of advanced healthcare infrastructure, favorable reimbursement policies, and high healthcare expenditure are likely to drive market growth. Canada, on the other hand, is witnessing an increase in awareness about sacroiliac joint disorders and a growing number of orthopedic clinics offering sacroiliac joint fusion procedures.

Asia Pacific:

In Asia Pacific, countries like China, Japan, and South Korea are anticipated to experience rapid growth in the sacroiliac joint fusion market. Growing healthcare infrastructure, increasing disposable income, and rising healthcare expenditure in these countries are driving market growth. In China, the high prevalence of sacroiliac joint disorders and the government's focus on improving healthcare facilities are expected to fuel market growth. Japan and South Korea are witnessing a surge in the number of orthopedic surgeries and advancements in medical technology, which are likely to boost the market for sacroiliac joint fusion procedures.

Europe:

In Europe, countries like the United Kingdom, Germany, and France are expected to have a strong presence in the sacroiliac joint fusion market. The increasing incidence of sacroiliac joint disorders, growing elderly population, and advancements in surgical techniques are expected to drive market growth in these countries. The United Kingdom is witnessing a rise in the demand for minimally invasive surgical procedures, while Germany and France are focusing on enhancing healthcare facilities and promoting the adoption of sacroiliac joint fusion procedures. These factors are likely to propel market growth in the European region.

Segmentation Analysis:

In terms of segmentation, the global sacroiliac joint fusion market is analyzed on the basis of Indication, Treatment Type, End-User.

Segment Analysis:

Degenerative Sacroiliitis: The degenerative sacroiliitis indication segment holds a significant share in the sacroiliac joint fusion market. This is attributed to the rising prevalence of degenerative sacroiliitis among individuals, especially in the aging population. Degenerative sacroiliitis is characterized by inflammation in the sacroiliac joint, leading to chronic pain and discomfort. The increasing adoption of surgical interventions and injections for the treatment of degenerative sacroiliitis is driving the growth of this segment in the market.

Sacral Disruption: The sacral disruption indication segment is also witnessing significant growth in the sacroiliac joint fusion market. Sacral disruption refers to the instability or malalignment of the sacrum, leading to pain and dysfunction in the sacroiliac joint. This indication is commonly seen in trauma patients or those with previous pelvic surgeries. The demand for surgical interventions to stabilize the sacroiliac joint in cases of sacral disruption is fueling the growth of this segment in the market.

Treatment Type:

Surgery: The surgery treatment type segment dominates the sacroiliac joint fusion market, owing to the widespread adoption of surgical interventions for the management of sacroiliac joint disorders. Surgical procedures such as minimally invasive sacroiliac joint fusion are gaining popularity due to their effectiveness in providing long-term relief from pain and improving functional outcomes. The increasing number of surgical centers and advancements in surgical techniques are further contributing to the growth of this segment in the market.

Injections: The injections treatment type segment is also witnessing considerable growth in the sacroiliac joint fusion market. Injections, such as corticosteroids and platelet-rich plasma, are commonly used to provide temporary relief from sacroiliac joint pain and inflammation. These non-invasive treatment options are preferred by patients who are not suitable candidates for surgery or those looking for conservative approaches to manage their symptoms. The growing focus on pain management and the availability of advanced injection therapies are driving the growth of this segment in the market.

End-user:

Hospitals: Hospitals represent the largest end-user segment in the sacroiliac joint fusion market, as they serve as primary centers for the diagnosis and treatment of sacroiliac joint disorders. The availability of multidisciplinary teams, advanced surgical facilities, and specialized medical equipment in hospitals make them preferred choices for patients seeking treatment for sacroiliac joint conditions. The increasing number of hospital admissions for sacroiliac joint fusion procedures is contributing to the growth of this segment in the market.

Ambulatory Surgical Centers (ASCs): Ambulatory surgical centers are emerging as key end-users in the sacroiliac joint fusion market, owing to their convenience and cost-effectiveness for patients undergoing surgical interventions. ASCs offer outpatient procedures for sacroiliac joint fusion, allowing patients to return home on the same day of surgery. The streamlined processes, personalized care, and quicker recovery times associated with ASCs are driving the growth of this segment in the market.

Competitive Landscape:

The competitive landscape in the Sacroiliac Joint Fusion Market is highly competitive with a number of key players striving to expand their market share and offer innovative products and solutions. Companies are focusing on research and development activities, strategic partnerships, and acquisitions to enhance their product portfolio and cater to the evolving needs of the consumers. The market is witnessing a growing demand for minimally invasive procedures for the treatment of sacroiliac joint dysfunction, which is driving the competition among the players in the market.

Top Market Players:

1. Medtronic

2. Stryker Corporation

3. Zimmer Biomet Holdings, Inc.

4. Globus Medical, Inc.

5. SI-BONE, Inc.

6. RTI Surgical Holdings, Inc.

7. Osseus Fusion Systems

8. K2M Group Holdings, Inc.

9. Zimmer Biomet Holdings, Inc.

10. Xtant Medical Holdings, Inc.